Anzeige
Mehr »
Login
Freitag, 10.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
12 Leser
Artikel bewerten:
(0)

Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect

DUBLIN, February 14, 2014 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/2pvccf/autoinjectors_to) has announced the addition of the"Autoinjectors to 2018 Devices, Therapeutics, Markets, Strategies and Prospect"report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

While autoinjectors are sometimes designed to work with a particular injectable product as a form of pharmaceutical branding, the typical autoinjector is designed to fit one or more standard sizes of prefilled disposable syringes. Until recently, autoinjectors were designed to be reused. The reason was that the injectors were too expensive to be successfully marketed as a throw-away device. Recent improvements in materials technology and device design have led to the creation of a class of autoinjectors that can be made economically in high production quantities, opening the door for the disposable autoinjector, and providing expanded opportunities for both patient and drug marketer.

Highlights

  • Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments
  • Analyzes design factors, material selection issues, technologies and market development issues
  • Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Charts market data and forecasts to 2018

Key Topics Covered:

Executive Summary

Injectable Drug Delivery Market Dynamics

The Economics of Injectable Drugs
What's Driving the Growth in Autoinjectors?
Prefilled Syringes Proliferating
The Trend toward Self-Administration
Shifting Demographics
Innovation in Disposable Device Designs
Therapeutic Demand Drivers
Competitive Landscape
Risk Factors

Autoinjectors - Commercial Devices

Manual injection Autoinjectors
Automated Injection Autoinjectors
Reusable Autoinjectors
Disposable Autoinjectors
Bundled (Pre-assembled) Autoinjectors
Product Specific Autoinjectors

Autoinjector Device Design Factors

Material Selection Issues
Part Counts and Device Cost
Safety Features
Needle Shielding
Needle Insertion Depth
Failsafe Activation
Dose Inspection/Injection Confirmation
Lyophilized Drugs/Reconstitution
Human Engineering/Ergonomics

Autoinjector Drug Delivery - Key Therapeutic Sector Analysis

Anticoagulants
Autoimmune Diseases
Rheumatoid Arthritis
Multiple Sclerosis
Psoriasis
Emergency Medicine
Hepatitis
Hematopoietics
Hormones
Reproductive Health

Market Factors

Regulatory Issues
Device Branding
Patient Compliance
Healthcare Economics
Ease of Use

Autoinjector Devices - Company Profiles

For more information visithttp://www.researchandmarkets.com/research/2pvccf/autoinjectors_to

Media Contact:Laura Wood, +353-1-481-1716, press@researchandmarkets.net

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.